Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)

Affiliations

¹ Gastroenterology Department, Hospital de Galdakao and Biocruces Bizkaia Health Research Institute, Galdakao, Spain. Electronic address: iago.r.lago@gmail.com.
² Hospital Universitario Araba, Vitoria, Spain.
³ Gastroenterology Department, Hospital de Galdakao and Biocruces Bizkaia Health Research Institute, Galdakao, Spain.
⁴ Gastroenterology Department, Hospital Universitario de Cruces, Barakaldo, Spain.
⁵ Gastroenterology Department, Hospital Universitario de Basurto, Bilbao, Spain.

Iago Rodríguez-Lago et al. Gastroenterology. 2020 Aug.

. 2020 Aug;159(2):781-783.

doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21.

¹ Gastroenterology Department, Hospital de Galdakao and Biocruces Bizkaia Health Research Institute, Galdakao, Spain. Electronic address: iago.r.lago@gmail.com.
² Hospital Universitario Araba, Vitoria, Spain.
³ Gastroenterology Department, Hospital de Galdakao and Biocruces Bizkaia Health Research Institute, Galdakao, Spain.
⁴ Gastroenterology Department, Hospital Universitario de Cruces, Barakaldo, Spain.
⁵ Gastroenterology Department, Hospital Universitario de Basurto, Bilbao, Spain.

No abstract available

Keywords: COVID-19; Immunosuppression; Inflammatory Bowel Disease; SARS-CoV-2.

Comment in

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
Macaluso FS, Orlando A. Macaluso FS, et al. Gastroenterology. 2021 Apr;160(5):1877-1878. doi: 10.1053/j.gastro.2020.05.026. Epub 2020 May 12. Gastroenterology. 2021. PMID: 32407807 Free PMC article. No abstract available.
Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.
Rodríguez-Lago I, Alonso-Galán H, Cabriada JL. Rodríguez-Lago I, et al. Gastroenterology. 2021 Apr;160(5):1878-1880. doi: 10.1053/j.gastro.2020.12.073. Epub 2021 Jan 5. Gastroenterology. 2021. PMID: 33417936 No abstract available.